We attended the ASCO 2022 annual meeting in Chicago. We came away encouraged from the meeting. The unmet medical need in oncology remains high and new technologies and diagnostic approaches have started to make in-roads into the market. While opportunities will become smaller due to better patient stratification, and competition and complexity is significantly increasing, we believe that all the same strong new winners will evolve (bispecifics, ADC’s, cell therapies, ctDNA testing).
For this month, our "Chart of the Month” becomes a “Discussion of the Month”. View Urban Fritsche's, Raphael Oesch and Flavio Mancino key takeaways from this month's conferences in the US.
We attended the 43th annual Goldman Sachs Healthcare Conference 2022 from June 13th to 16th in Los Angeles, where we focussed mostly on Medtech and Service companies. We came away convinced that the healthcare sector will once again prove its defensive qualities as the dynamics of the healthcare market are less affected by the current macroeconomic backdrop.
The Kieger Healthcare team attended the Jefferies Healthcare Conference in New York from June 8th to June 10th 2022. This year, the overarching theme was the state of the Healthcare sector in the current cloudy macro environment. Many presentations touched on the pain-points investors are currently dealing with. In general, companies painted a confident picture for the future.